If you need more lookups,
subscriptions start at $34 USD/month.
Nesrin Ercelen Location
Istanbul, Turkey
Nesrin Ercelen Work
Medical Genetics Graduate Program Director @ (January 2024 - Present)
Professor @ (May 2022 - Present)
Founder @ (October 2006 - Present)
Medical Doctor @ (September 2000 - Present)
Co-Founder, Scientific Director @ GENEIS Genetic System Solutions (May 2006 - Present)
Dean of Halic University Medical School @ Halic University (August 2021 - January 2022)
Medical Director @ AtiGen-Cell Tissue and Stem Cell Center (January 2019 - January 2021)
Visiting Professor @ University of California Irvine, School of Medicine, Department of Medical Genet (January 2018 - January 2019)
Regenerative Medicine and Stem Cell Research and Application Clinic, Scientific Director @ BAU Medical School, Dept of Medical Genetics, Liv Hospital Istanbul, Regenerativ (July 2012 - March 2016)
Nesrin Ercelen Education
Hacettepe University Medical School 1993
TED Ankara Koleji 1986
Nesrin Ercelen Skills
Biochemistry
Biotechnology
Cell
Cell Biology
Cell Culture
Clinical Development
Clinical Research
Drug Discovery
Genetic
Genetic Analysis
Genetic Counseling
Genetic Engineering
Genetic Programming
Genetic Testing
Genetics
Genomics
Healthcare
Human Genetics
Immunology
Lifesciences
Medical Education
Medical Genetics
Medicine
Molecular Biology
Molecular Genetics
Oncology
Pharmaceutical Industry
Regenerative Medicine
Stem Cell Research
Nesrin Ercelen Summary
Nesrin Ercelen, based in Istanbul, Turkey, is currently a Medical Genetics Graduate Program Director at Üsküdar University. Nesrin Ercelen brings experience from previous roles at Üsküdar University, Geneis Genetik Hastalıklar Değerlendirme Merkezi, American Hospital and GENEIS Genetic System Solutions. Nesrin Ercelen holds a Hacettepe University Medical School. With a robust skill set that includes Biochemistry, Biotechnology, Cell, Cell Biology, Cell Culture and more. Nesrin Ercelen has 2 emails on RocketReach.
Looking for a different Nesrin Ercelen?
Find contact details for 700 million professionals.